Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/28/2011 | CN102199201A Recombinant fungal immunomodulatory protein gene in Ganoderma lucidum, protein coded whereby and application thereof |
09/28/2011 | CN102199200A Method for preparing high-purity nisin |
09/28/2011 | CN102199199A Membrane localization staphylococcal enterotoxin A and gene sequence thereof |
09/28/2011 | CN102199198A Purification method of F protein of human respiratory syncytial virus |
09/28/2011 | CN102199197A Polypeptides with function of self-assembled potassium channel and its application |
09/28/2011 | CN102199196A Gene engineering antibacterial peptide and preparation method and application thereof |
09/28/2011 | CN102199188A Liquid-phase synthesis method for polypeptide |
09/28/2011 | CN102198269A Application of Brucella GroEL protein and method for recombinant expression of Brucella GroEL protein |
09/28/2011 | CN102198266A Cancer antigens based on tumor suppressor gene WT1 product |
09/28/2011 | CN102198263A Application of ipomoea batatas Sporamin protein in preparation of medicines for treating and preventing tumours and health products |
09/28/2011 | CN101942016B Rice protein OsCPN1 as well as encoding gene and application thereof |
09/28/2011 | CN101838323B Anti-platelet thrombolysin and preparation method thereof |
09/28/2011 | CN101812462B Application of rice GT transcription factor family gene OsGT gamma-1 in controlling salt tolerance of rice |
09/28/2011 | CN101619101B Rhinolophus ferrumequinum leptin protein and cDNA sequence thereof |
09/28/2011 | CN101570755B Novel gene of virus original protease inhibitor as well as expression and application thereof |
09/28/2011 | CN101555275B Method for preparing alpha-amylase inhibitor by enzymatic method |
09/28/2011 | CN101519442B Method for inducing silkworms to produce antibacterial peptides |
09/28/2011 | CN101445546B Preparation for tussore silk fibroin solution and concentration method thereof |
09/28/2011 | CN101434960B Protective antigen mutant of Bacillus anthracis |
09/28/2011 | CN101358190B Artificially synthetic high gene sequence expressing high virulence protein for lepidoptera pest and use thereof |
09/28/2011 | CN101333531B CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
09/28/2011 | CN101253194B Growth-stimulating polypeptides for use in fish and crustaceans |
09/27/2011 | US8026415 Enhancing disease resistance of plants, such as soybean resistant to Phakopsora pachyrhizi |
09/27/2011 | US8026414 Molecular marker associated with CMV resistance and use thereof |
09/27/2011 | US8026353 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases |
09/27/2011 | US8026351 Monocyte-derived nucleic acids and related compositions and methods |
09/27/2011 | US8026350 Tumor suppressor gene, p28ING5 |
09/27/2011 | US8026346 Tribonectins |
09/27/2011 | US8026341 Transfection complexes |
09/27/2011 | US8026224 Tumor cells with increased immunogenicity and uses therfor |
09/27/2011 | US8026215 Methods and compositions for control of fetal growth via modulation of relaxin |
09/27/2011 | US8026213 Methods for treating muscle diseases and disorders |
09/27/2011 | US8026210 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
09/27/2011 | US8026209 Administering a diagnostic agent with a carrier conjugated to a targeting molecule that binds to a lipopolysaccharide-sensitive polypeptide, which is either up-regulated or down-regulated in ECs by exposure to LPS; delivery into the EC vascular barrier and/or across the EC vascular barrier |
09/27/2011 | US8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction |
09/27/2011 | US8026096 In vivo active erythropoietin produced in insect cells |
09/27/2011 | US8026092 Replication competent hepatitis C virus and methods of use |
09/27/2011 | US8026089 Mutant Δ8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids |
09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
09/27/2011 | US8026069 Process for identification of compounds for modulating the activity of sodium/calcium exchange transporter |
09/27/2011 | US8026051 Peptide nucleic acid probe for detection of yeast |
09/27/2011 | US8026050 Methods for modifying an oligonucleotide |
09/27/2011 | US8025891 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
09/27/2011 | US8025890 Nucleic acids and proteins from streptococcus groups A and B |
09/27/2011 | US8025889 Botulinum toxin administration to treat various conditions |
09/27/2011 | US8025887 Avirulent, immunogenic flavivirus chimeras |
09/27/2011 | US8025884 Lawsonia intracellularis subunit vaccines |
09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
09/27/2011 | US8025879 Modified glycoproteins and uses thereof |
09/27/2011 | US8025876 Antibodies against a peptide epitope of apolipoprotein B |
09/27/2011 | US8025873 Chimeric antigens for eliciting an immune response |
09/27/2011 | CA2537421C Peptides and compounds that bind to thrombopoietin receptor |
09/27/2011 | CA2510313C Saposin c and receptors as targets for treatment of benign and malignant disorders |
09/27/2011 | CA2468849C Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
09/27/2011 | CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
09/27/2011 | CA2447276C Non-human animal model of oligodendrocyte developmental disorder |
09/27/2011 | CA2408034C Recombinant sequence, its preparation and use |
09/27/2011 | CA2377519C Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
09/27/2011 | CA2372553C Attenuated microorganisms for the treatment of infection |
09/27/2011 | CA2369973C Preparation of pancreatic procarboxypeptidase b, isoforms and muteins thereof and their use |
09/27/2011 | CA2336218C Neurotrophic factors |
09/27/2011 | CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies |
09/22/2011 | WO2011116396A2 Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists |
09/22/2011 | WO2011116245A2 Methods of treating inflammation |
09/22/2011 | WO2011116209A2 Using phage epitopes to profile the immune response |
09/22/2011 | WO2011116094A2 Live attenuated chimeric porcine circovirus vaccine |
09/22/2011 | WO2011115937A1 Methods of determining susceptibility of tumors to tyrosine kinase inhibitors |
09/22/2011 | WO2011115819A2 Small molecule inhibitors of muc1 and methods of identifying the same |
09/22/2011 | WO2011115583A1 A novel platform for retrovirus-like particle (vlp)-display of vaccine antigens |
09/22/2011 | WO2011115562A1 Antimicrobial compound |
09/22/2011 | WO2011115483A1 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
09/22/2011 | WO2011115479A1 Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals |
09/22/2011 | WO2011115420A2 Adhesive extracellular matrix mimetic |
09/22/2011 | WO2011115323A1 Composition for inhibiting cancer metastasis containing dlk1-fc fusion protein as an active ingredient |
09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
09/22/2011 | WO2011115222A1 Florigen-activating complex |
09/22/2011 | WO2011115070A1 Transformant which produces glycine repeat protein |
09/22/2011 | WO2011114405A1 A method for binding a protein consisting of protein a or consisting of at least one domain of the a to e domains of the protein a to the substrate |
09/22/2011 | WO2011114063A2 Novel signal peptide, and use thereof for producing recombinant proteins |
09/22/2011 | WO2011113999A1 New polypeptides from endophytes of empetrum nigrum and their fragments, encoding them, their production and uses |
09/22/2011 | WO2011113869A1 Canine astrovirus astv strain bari/08 identified in dogs with gastro-enteritis |
09/22/2011 | WO2011113839A1 Method for modifying the blooming date of a plant |
09/22/2011 | WO2011113618A1 Immune therapy |
09/22/2011 | WO2011113601A1 Method for obtaining biologically active recombinant human g-csf |
09/22/2011 | WO2011113592A1 Method for production of polymer containing fibres |
09/22/2011 | WO2011113579A2 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
09/22/2011 | WO2011113546A1 Tumor vaccination involving a humoral immune response against self-proteins |
09/22/2011 | WO2011113446A1 Method for production of polypeptide containing fibres |
09/22/2011 | WO2011113160A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
09/22/2011 | WO2011094617A3 Peptide domains that bind small molecules of industrial significance |
09/22/2011 | WO2011091389A3 Cyclovirus and method of use |
09/22/2011 | WO2011057063A3 Compositions and methods for quantitatively monitoring lipids |
09/22/2011 | WO2011053798A3 Peptide compositions and methods for inhibiting herpesvirus infection |
09/22/2011 | WO2007127834A3 Compositions and methods of preparation thereof |
09/22/2011 | US20110231963 Modified bacillus thuringiensis cry14 proteins for nematode control |
09/22/2011 | US20110231961 Metabolic regulators |
09/22/2011 | US20110231960 Bacterial toxin vaccine |
09/22/2011 | US20110231952 Soybean nodulation factor receptor proteins, encoding nucleic acids and uses therefor |
09/22/2011 | US20110231946 Engineering of bolting resistance in sugar beet by means of the transgenic expression of the beet homologue of flowering time control gene ft |
09/22/2011 | US20110231942 Tiki1 and tiki2, wnt inhibitors |